Silvia Scaglione received her PhD in bioengineering at the University of Genoa (I) in 2005. In 2004, she was Visiting Scientist at the University Hospital of Basel (CH). Since 2010, Scaglione has been a permanent researcher (senior researcher since 2021) at the National Council of Research (CNR). She is the founder and chief scientist of React4life, an Italian biotech company that develops organ-on-chip technologies for medical research, winning several international projects and awards, such as the Innovation Radar Award from the EU for the best health technology. Scaglione is also the author of more than 80 international peer-reviewed papers and book chapters and the author of seven patents. She has tutored more than 50 master/PhD students and is a reviewer of several national/international research projects. Scaglione is currently the PI of a Future Emerging Technology European H2020 project on a spontaneous cancer model in vitro (B2B). She has been Ambassador of the European Innovation Council and Gamma Donna Ambassador since 2021.
CNR
Genoa, Liguria, Italy
React4life S.p.A.
Genoa, Liguria, Italy
EIC ambassador
European Commission
President, CEO or Director
React4life
01 Oct 2017 - present
Senior Scientist or Principal Investigator
CNR
01 Nov 2010 - present
Post Doctoral Researcher
University Genoa
01 Jun 2005 - 01 Nov 2010